PT839134E - Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica - Google Patents
Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinapticaInfo
- Publication number
- PT839134E PT839134E PT96916599T PT96916599T PT839134E PT 839134 E PT839134 E PT 839134E PT 96916599 T PT96916599 T PT 96916599T PT 96916599 T PT96916599 T PT 96916599T PT 839134 E PT839134 E PT 839134E
- Authority
- PT
- Portugal
- Prior art keywords
- improving
- compounds
- pyrrolidines
- subjects
- ampa receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/458,967 US5650409A (en) | 1995-06-02 | 1995-06-02 | Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT839134E true PT839134E (pt) | 2004-07-30 |
Family
ID=23822840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96916599T PT839134E (pt) | 1995-06-02 | 1996-05-23 | Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5650409A (pt) |
| EP (1) | EP0839134B1 (pt) |
| JP (1) | JP3464800B2 (pt) |
| KR (2) | KR100621499B1 (pt) |
| AT (1) | ATE259788T1 (pt) |
| AU (1) | AU708715B2 (pt) |
| CA (1) | CA2222976C (pt) |
| DE (1) | DE69631588T2 (pt) |
| DK (1) | DK0839134T3 (pt) |
| ES (1) | ES2216048T3 (pt) |
| PL (1) | PL187895B1 (pt) |
| PT (1) | PT839134E (pt) |
| WO (1) | WO1996038414A1 (pt) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU721936B2 (en) * | 1996-04-03 | 2000-07-20 | Regents Of The University Of California, The | Benzoxazines for enhancing synaptic response |
| US5736543A (en) * | 1996-04-03 | 1998-04-07 | The Regents Of The University Of California | Benzoxazines for enhancing synaptic response |
| AU714477B2 (en) * | 1996-04-19 | 2000-01-06 | Regents Of The University Of California, The | Treatment of mood/affective disorders by glutamatergic upmodulators |
| AU4416197A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Positive ampa receptor modulation to enhance brain neurotrophic factor expression |
| US6110935A (en) * | 1997-02-13 | 2000-08-29 | The Regents Of The University Of California | Benzofurazan compounds for enhancing glutamatergic synaptic responses |
| US6329368B1 (en) | 1997-05-09 | 2001-12-11 | The Regents Of The University Of California | Endocrine modulation with positive modulators of AMPA type glutamate receptors |
| DK1026950T3 (da) * | 1997-10-27 | 2006-06-26 | Univ California | Behandling af skizofreni med ampakiner og neuroleptika |
| US5985871A (en) * | 1997-12-24 | 1999-11-16 | Cortex Pharmaceuticals, Inc. | Benzoxazine compounds for enhancing synaptic response |
| US6943159B1 (en) | 1998-02-18 | 2005-09-13 | Neurosearch A/S | Compounds and their use as positive AMPA receptor modulators |
| US6124278A (en) * | 1998-04-03 | 2000-09-26 | The Regents Of The University Of California | Acylbenzoxazines for enhancing synaptic response |
| TWI232863B (en) | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
| HUP0400196A3 (en) * | 2001-06-14 | 2007-05-02 | Organon Nv | (pyrido/thieno)[f]oxazepin-5-one derivatives, their use and pharmaceutical compositions containing them |
| MXPA04004815A (es) * | 2001-11-26 | 2005-02-17 | Cortex Pharma Inc | Compuestos de carbonilbenzoxazina para mejorar respuestas sinapticas, glutamatergicas. |
| NZ540468A (en) | 2003-01-13 | 2008-03-28 | Univ California | Method of treating cognitive decline due to sleep deprivation and stress using an AMPA receptor potentiator |
| US20060063707A1 (en) * | 2004-09-17 | 2006-03-23 | Lifelike Biomatic, Inc. | Compositions for enhancing memory and methods therefor |
| TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
| US20100041647A1 (en) * | 2007-01-03 | 2010-02-18 | Cortex Pharmaceuticals, Inc. | 3-Substituted-[1,2,3]-Benzotriazinone compounds for enhancing glutamatergic synaptic responses |
| AU2007342365B2 (en) * | 2007-01-03 | 2012-11-15 | Les Laboratoires Servier | 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses |
| CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
| CA2680737C (en) * | 2007-03-21 | 2015-12-15 | Emisphere Technologies, Inc. | Allyloxy and alkyloxy benzoic acid delivery agents |
| JP5694765B2 (ja) * | 2007-05-17 | 2015-04-01 | コーテックス ファーマシューティカルズ， インコーポレイテッド | グルタミン酸作動性シナプス反応を増強するための二置換アミド |
| BRPI0814149A2 (pt) * | 2007-08-10 | 2011-09-13 | Cortex Pharma Inc | composto, composição farmacêutica, métodos de tratamento e uso do composto |
| US8119632B2 (en) | 2007-08-10 | 2012-02-21 | Cortex Pharmaceuticals, Inc. | Bicyclic amide derivatives for enhancing glutamatergic synaptic responses |
| US20110218190A1 (en) * | 2008-11-10 | 2011-09-08 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| WO2011109398A2 (en) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
| EP2701727B1 (en) | 2011-03-04 | 2019-05-08 | The Regents of The University of California | Locally released growth factors to mediate motor recovery after stroke |
| US10555916B2 (en) | 2013-01-25 | 2020-02-11 | Case Western Reserve University | NMDAR antagonist for the treatment of pervasive development disorders |
| BR112015031249A2 (pt) | 2013-06-13 | 2017-07-25 | Veroscience Llc | método de tratamento, método para tratar um distúrbio metabólico ou um elemento chave do mesmo, método para normalizar um ritmo diário de liberação de dopamina no sumn, método para estimular a liberação de dopamina de neurônios dopaminérgicos no sumn de um indivíduo e composição farmacêutica |
| GB201510010D0 (en) | 2015-06-09 | 2015-07-22 | King S College London | PDD and BPD compounds |
| US20180339985A1 (en) | 2015-08-21 | 2018-11-29 | Femtogenix Limited | Pdd compounds |
| GB201514928D0 (en) | 2015-08-21 | 2015-10-07 | King S College London | PDD compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3406177A (en) * | 1965-05-12 | 1968-10-15 | Johnson & Son Inc S C | N-(meta-toluyl)-methylpiperidines |
| US3463855A (en) * | 1965-05-12 | 1969-08-26 | Johnson & Son Inc S C | Insect repellent compositions of n-(meta-toluyl)-methyl piperidines |
| JPH01207284A (ja) * | 1987-10-06 | 1989-08-21 | Takeda Chem Ind Ltd | アミド化合物 |
| ATE253909T1 (de) * | 1992-07-24 | 2003-11-15 | Univ California | Arzneimittel die den durch ampa rezeptoren vermittelten synaptischen response erhöhen |
-
1995
- 1995-06-02 US US08/458,967 patent/US5650409A/en not_active Expired - Fee Related
-
1996
- 1996-05-23 DE DE69631588T patent/DE69631588T2/de not_active Expired - Lifetime
- 1996-05-23 AT AT96916599T patent/ATE259788T1/de active
- 1996-05-23 AU AU59293/96A patent/AU708715B2/en not_active Ceased
- 1996-05-23 EP EP96916599A patent/EP0839134B1/en not_active Expired - Lifetime
- 1996-05-23 CA CA002222976A patent/CA2222976C/en not_active Expired - Fee Related
- 1996-05-23 PT PT96916599T patent/PT839134E/pt unknown
- 1996-05-23 WO PCT/US1996/007607 patent/WO1996038414A1/en active IP Right Grant
- 1996-05-23 KR KR1020037016547A patent/KR100621499B1/ko not_active IP Right Cessation
- 1996-05-23 ES ES96916599T patent/ES2216048T3/es not_active Expired - Lifetime
- 1996-05-23 DK DK96916599T patent/DK0839134T3/da active
- 1996-05-23 KR KR1019970708728A patent/KR100444539B1/ko not_active IP Right Cessation
- 1996-05-23 PL PL96323667A patent/PL187895B1/pl not_active IP Right Cessation
- 1996-05-23 JP JP53656896A patent/JP3464800B2/ja not_active Expired - Fee Related
-
1997
- 1997-03-21 US US08/822,027 patent/US5783587A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040004716A (ko) | 2004-01-13 |
| DE69631588T2 (de) | 2004-12-16 |
| US5650409A (en) | 1997-07-22 |
| KR100444539B1 (ko) | 2004-10-14 |
| CA2222976A1 (en) | 1996-12-05 |
| KR19990022249A (ko) | 1999-03-25 |
| KR100621499B1 (ko) | 2006-09-14 |
| PL323667A1 (en) | 1998-04-14 |
| CA2222976C (en) | 2001-04-24 |
| PL187895B1 (pl) | 2004-10-29 |
| EP0839134B1 (en) | 2004-02-18 |
| WO1996038414A1 (en) | 1996-12-05 |
| JP3464800B2 (ja) | 2003-11-10 |
| ES2216048T3 (es) | 2004-10-16 |
| DE69631588D1 (de) | 2004-03-25 |
| AU5929396A (en) | 1996-12-18 |
| JP2001503012A (ja) | 2001-03-06 |
| DK0839134T3 (da) | 2004-08-16 |
| ATE259788T1 (de) | 2004-03-15 |
| AU708715B2 (en) | 1999-08-12 |
| US5783587A (en) | 1998-07-21 |
| EP0839134A1 (en) | 1998-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT839134E (pt) | Benzoilpiperidinas/pirrolidinas para melhoramento da resposta sinaptica | |
| ATE226206T1 (de) | Benzoxazine zur erhöhung der synaptischen reaktionen | |
| CA2138533A1 (en) | Drugs that enhance synaptic responses mediated by ampa receptors | |
| PT1054673E (pt) | Compostos de benzoxazina para melhorar a resposta sinaptica | |
| DE69834590D1 (de) | Benzofurazanderivate und deren verwendung zur verbesserung glutaminerger synaptischer antworten | |
| PT1067935E (pt) | Acilbenzoxazinas para melhorar resposta (s) sinaptica (s) | |
| EA200400584A1 (ru) | Соединения карбонилбензоксазина для усиления глутаматергических синаптических ответов | |
| Van Doren et al. | A triplex model of cutaneous mechanoreception |